Beginning with the mandatory reporting for the CY 2026 reporting period, we estimate a decrease in burden of approximately 729,045 hours for 21,871,350 patients (4,765 patients 4,590 ASCs 0.033 hours per patient) at a savings of $18,685,423 (729,045 hours $25.63/hour)
If you have a history of pancreatitis, gallbladder disease, or medullary thyroid carcinoma, GLP-1 agonists (including biomimetic alternatives) carry potential risks
Additionally, these medications encourage the body to use insulin more efficiently, which can be particularly effective for those with insulin resistance or type 2 diabetes
For structured support from a licensed clinician, QuickMD makes it easy to begin addiction treatment online
For those patients, the experience can look very different